190 related articles for article (PubMed ID: 24760750)
1. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
[TBL] [Abstract][Full Text] [Related]
2. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2011 Dec; 57(7):1222-9. PubMed ID: 22095929
[TBL] [Abstract][Full Text] [Related]
3. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
[TBL] [Abstract][Full Text] [Related]
4. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study.
Skou AS; Olsen SØ; Nielsen LH; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e12-e17. PubMed ID: 30550508
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.
Mulder RL; Kremer LC; Koot BG; Benninga MA; Knijnenburg SL; van der Pal HJ; Koning CC; Oldenburger F; Wilde JC; Taminiau JA; Caron HN; van Dalen EC
Eur J Cancer; 2013 Jan; 49(1):185-93. PubMed ID: 22901831
[TBL] [Abstract][Full Text] [Related]
6. Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Jarfelt M; Andersen NH; Glosli H; Jahnukainen K; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Eur J Haematol; 2016 Jul; 97(1):55-62. PubMed ID: 26383901
[TBL] [Abstract][Full Text] [Related]
7. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
Br J Haematol; 2010 Dec; 151(5):447-59. PubMed ID: 20955398
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
Espersen ADL; Noren-Nyström U; Abrahamsson J; Ha SY; Pronk CJ; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Palmqvist L; Hasle H
Genes Chromosomes Cancer; 2018 Jul; 57(7):359-365. PubMed ID: 29569294
[TBL] [Abstract][Full Text] [Related]
9. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.
Hasle H; Kerndrup G; Yssing M; Clausen N; Ostergaard E; Jacobsen N; Jacobsen BB
Leukemia; 1996 Aug; 10(8):1269-73. PubMed ID: 8709630
[TBL] [Abstract][Full Text] [Related]
10. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.
Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Zeller B; Gustafsson G; ;
Leukemia; 2005 Dec; 19(12):2090-100. PubMed ID: 16304571
[TBL] [Abstract][Full Text] [Related]
11. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
[TBL] [Abstract][Full Text] [Related]
12. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
Molgaard-Hansen L; Möttönen M; Glosli H; Jónmundsson GK; Abrahamsson J; Hasle H;
Br J Haematol; 2011 Mar; 152(5):623-30. PubMed ID: 21241281
[TBL] [Abstract][Full Text] [Related]
13. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
[TBL] [Abstract][Full Text] [Related]
16. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
17. The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan.
Yeh TC; Liu HC; Wang LY; Chen SH; Lin WY; Liang DC
J Pediatr Hematol Oncol; 2007 Dec; 29(12):826-31. PubMed ID: 18090930
[TBL] [Abstract][Full Text] [Related]
18. Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01.
Løhmann DJA; Asdahl PH; Abrahamsson J; Ha SY; Jónsson ÓG; Kaspers GJL; Koskenvuo M; Lausen B; De Moerloose B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2019 Jun; 66(6):e27701. PubMed ID: 30848067
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
Stefanski KJ; Anixt JS; Goodman P; Bowers K; Leisenring W; Scott Baker K; Burns K; Howell R; Davies S; Robison LL; Armstrong GT; Krull KR; Recklitis C
J Natl Cancer Inst; 2021 Apr; 113(4):481-495. PubMed ID: 32797189
[TBL] [Abstract][Full Text] [Related]
20. Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program.
Barlogis V; Auquier P; Bertrand Y; Chastagner P; Plantaz D; Poiree M; Kanold J; Berbis J; Oudin C; Vercasson C; Allouche M; Tabone MD; Thouvenin-Doulet S; Saumet L; Chambost H; Baruchel A; Leverger G; Michel G
Haematologica; 2015 May; 100(5):e186-9. PubMed ID: 25616572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
